Ghost Tree Capital’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Ghost Tree Capital’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-35,801	Closed	-$68K	–	107
2016 Q2	$68K	Sell	35,801 -9,199	-20%	-$24.2K	0.02%	63
2016 Q1	$132K	Sell	45,000 -80,000	-64%	-$228K	0.07%	51
2015 Q4	$390K	Hold	125,000	–	–	0.16%	47
2015 Q3	$395K	Hold	125,000	–	–	0.18%	69
2015 Q2	$475K	Hold	125,000	–	–	0.15%	65
2015 Q1	$589K	Hold	125,000	–	–	0.21%	62
2014 Q4	$796K	Hold	125,000	–	–	0.38%	54
2014 Q3	$613K	Buy	125,000 +25,000	+25%	+$144K	0.33%	61
2014 Q2	$764K	Sell	100,000 -135,000	-57%	-$1.08M	0.54%	48
2014 Q1	$2.48M	Buy	235,000 +160,000	+213%	+$2.29M	1.47%	25
2013 Q4	$974K	Buy	+75,000	New	+$701K	0.6%	49

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ghost Tree Capital's OCRX Position: Q3 2016 in Review

Ghost Tree Capital sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2016, closing a stake of 35,801 shares — an estimated $68K sold.

Ghost Tree Capital first reported a position in OCRX in Q4 2013 and held it in 11 quarters. The position peaked at $2.48M in Q1 2014. 31 funds tracked by Wall St. Rank hold OCRX as of Q3 2016.

Ghost Tree Capital reported no remaining Ocera Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
Ghost Tree Capital sold 35,801 Ocera Therapeutics, Inc. shares in Q3 2016, an estimated $68K.
Ghost Tree Capital first reported a position in Ocera Therapeutics, Inc. in Q4 2013 and held it in 11 quarters.
Ghost Tree Capital's Ocera Therapeutics, Inc. position peaked at $2.48M in Q1 2014.
31 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2016.

Based on Ghost Tree Capital's 13F filing for Q3 2016, filed 14 Nov 2016.